Schedule 13G ownership disclosure

GRACELL BIOTECHNOLOGIES INC

Security class unavailable · CUSIP: 38406L103

Event date: 2022-03-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-078087
Form type
SC 13G
Filer
Frazier Life Sciences Public Fund, L.P.
CIK
CIK 1863769
Filed
Mar 17, 2022
Reporting period
Mar 10, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub